Elevated serum hepatic transaminases in apical periodontitis individuals
International Endodontic Journal · 2024
DOI: 10.1111/iej.14109 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Endodontic Journal, 2024. Verfasst von María José Bordagaray und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Periodontal Biology, Faculty of Dentistry, Universidad de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Periapical Periodontitis, Alanine Transaminase, Aspartate Aminotransferases, Biomarkers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica, Agencia Nacional de Investigación y Desarrollo.
Abstract (Originalsprache)
Aim
Apical periodontitis (AP) is the chronic inflammation of the periradicular tissues in response to root canal infection. Whilst AP has been linked with systemic inflammation and noncommunicable diseases, its potential association with nonalcoholic fatty liver disease (NAFLD) is unknown. We aimed to evaluate the serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels as surrogate markers of hepatic injury, and the systemic inflammatory burden in otherwise healthy individuals with and without AP diagnosis. Methodology Cross‐sectional study. Individuals with AP ( n = 30) and healthy controls ( n = 29) were recruited. The number, mean diameter (mm) and periapical index of the apical lesions of endodontic origin (ALEO) were assessed. ALT and AST levels (pg/mL) were measured through enzyme‐linked immunosorbent assays. The serum levels of TNF‐α, IL‐4, IL‐9, IL‐10, IL‐17A and IL‐22 were evaluated by Multiplex assay. Inferential analysis was performed using t ‐test or Mann–Whitney tests according to data distribution and linear regression models. Data were analysed with StataV16 ( p < .05).
Results
ALT and AST levels were significantly higher in individuals with AP compared to controls ( p < .05). Serum inflammatory biomarkers showed no significant differences between the study groups. Bivariate and multivariate analyses confirmed that AP diagnosis was independently associated with ALT and AST elevations ( p < .05). Additionally, the number of ALEO positively influenced AST levels ( p = .002). IL‐22 on the other hand, was associated with reduced ALT levels ( p = .043).
Conclusion
AP is associated with higher serum hepatic transaminases ALT and AST, potentially contributing to NAFLD physiopathology in young adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Periodontal Biology, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.
- Department of Conservative Dentistry, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.
- Faculty of Dentistry, Universidad Andres Bello, Santiago, Chile.
- Department of Pathology and Oral Medicine, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.
ORCID-Profile: María José Bordagaray, Marcela Hernández
Förderung
- Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica
- Agencia Nacional de Investigación y Desarrollo
Zitieren
APA
Bordagaray, M. J., Pellegrini, E., Garrido, M., Hernández-Ríos, P., Villalobos, T., Fernández, A., & Hernández, M. (2024). Elevated serum hepatic transaminases in apical periodontitis individuals. International Endodontic Journal. https://doi.org/10.1111/iej.14109
Vancouver
Bordagaray MJ, Pellegrini E, Garrido M, Hernández-Ríos P, Villalobos T, Fernández A, et al. Elevated serum hepatic transaminases in apical periodontitis individuals. International Endodontic Journal. 2024. doi:10.1111/iej.14109
BibTeX
@article{Bordagaray2024,
author = {Bordagaray, María José and Pellegrini, Elizabeth and Garrido, Mauricio and Hernández-Ríos, Patricia and Villalobos, Thomas and Fernández, Alejandra and Hernández, Marcela},
title = {Elevated serum hepatic transaminases in apical periodontitis individuals},
journal = {International Endodontic Journal},
year = {2024},
doi = {10.1111/iej.14109}
}
EUVIMED